JPH0424343B2 - - Google Patents
Info
- Publication number
- JPH0424343B2 JPH0424343B2 JP63162883A JP16288388A JPH0424343B2 JP H0424343 B2 JPH0424343 B2 JP H0424343B2 JP 63162883 A JP63162883 A JP 63162883A JP 16288388 A JP16288388 A JP 16288388A JP H0424343 B2 JPH0424343 B2 JP H0424343B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- acid
- addition salt
- hydrochloride
- hydroxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 claims description 37
- 150000003839 salts Chemical class 0.000 claims description 32
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 10
- -1 3-(3,4-dihydroxyphenylethylamino)-1-(4-hydroxyphenyl)butan-1-one Chemical compound 0.000 claims description 9
- 239000003054 catalyst Substances 0.000 claims description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 6
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical compound [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 claims description 6
- PCDHSSHKDZYLLI-UHFFFAOYSA-N butan-1-one Chemical compound CCC[C]=O PCDHSSHKDZYLLI-UHFFFAOYSA-N 0.000 claims description 4
- 238000007327 hydrogenolysis reaction Methods 0.000 claims description 4
- 229910052763 palladium Inorganic materials 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 description 44
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 36
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 14
- JRWZLRBJNMZMFE-UHFFFAOYSA-N Dobutamine Chemical compound C=1C=C(O)C(O)=CC=1CCNC(C)CCC1=CC=C(O)C=C1 JRWZLRBJNMZMFE-UHFFFAOYSA-N 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 229960001089 dobutamine Drugs 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 4
- 229960001654 dobutamine hydrochloride Drugs 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- KWSLGOVYXMQPPX-UHFFFAOYSA-N 5-[3-(trifluoromethyl)phenyl]-2h-tetrazole Chemical compound FC(F)(F)C1=CC=CC(C2=NNN=N2)=C1 KWSLGOVYXMQPPX-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 229910001379 sodium hypophosphite Inorganic materials 0.000 description 3
- ANOUKFYBOAKOIR-UHFFFAOYSA-N 3,4-dimethoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1OC ANOUKFYBOAKOIR-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000010520 demethylation reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- SKHIBNDAFWIOPB-UHFFFAOYSA-N hydron;2-phenylethanamine;chloride Chemical compound Cl.NCCC1=CC=CC=C1 SKHIBNDAFWIOPB-UHFFFAOYSA-N 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WRRZKDVBPZBNJN-ONEGZZNKSA-N (e)-4-(4-methoxyphenyl)but-3-en-2-one Chemical compound COC1=CC=C(\C=C\C(C)=O)C=C1 WRRZKDVBPZBNJN-ONEGZZNKSA-N 0.000 description 1
- HIRLSMKURCRARB-UHFFFAOYSA-N 1-(4-methoxyphenyl)but-2-en-1-one Chemical compound COC1=CC=C(C(=O)C=CC)C=C1 HIRLSMKURCRARB-UHFFFAOYSA-N 0.000 description 1
- JKTORXLUQLQJCM-UHFFFAOYSA-N 4-phosphonobutylphosphonic acid Chemical compound OP(O)(=O)CCCCP(O)(O)=O JKTORXLUQLQJCM-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001335 demethylating effect Effects 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- BQKADKWNRWCIJL-UHFFFAOYSA-N dobutamine hydrochloride Chemical compound [Cl-].C=1C=C(O)C(O)=CC=1CC[NH2+]C(C)CCC1=CC=C(O)C=C1 BQKADKWNRWCIJL-UHFFFAOYSA-N 0.000 description 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical class NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- FRJMDYSVLCJWQC-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-4-(4-methoxyphenyl)butan-2-amine Chemical compound C1=CC(OC)=CC=C1CCC(C)NCCC1=CC=C(OC)C(OC)=C1 FRJMDYSVLCJWQC-UHFFFAOYSA-N 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229910001380 potassium hypophosphite Inorganic materials 0.000 description 1
- CRGPNLUFHHUKCM-UHFFFAOYSA-M potassium phosphinate Chemical compound [K+].[O-]P=O CRGPNLUFHHUKCM-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- WCJYTPVNMWIZCG-UHFFFAOYSA-N xylylcarb Chemical compound CNC(=O)OC1=CC=C(C)C(C)=C1 WCJYTPVNMWIZCG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は急激に低下した心臓収縮性及びシヨツ
クに卓効を有するドパミン誘導体であるドブタミ
ン用の新規中間体及びその製法並びにその新規中
間体を用いたドブタミン塩酸塩の製法に関する。[Detailed Description of the Invention] [Field of Industrial Application] The present invention provides a novel intermediate for dobutamine, a dopamine derivative that has an excellent effect on rapidly decreased cardiac contractility and shock, a method for producing the same, and a novel intermediate thereof. The present invention relates to the method for producing dobutamine hydrochloride used.
〔従来の技術〕
従来、ドブタミン・塩酸塩、即ち3,4−ジヒ
ドロキシ−N−[3−(4−ヒドロキシフエニル)
−1−メチル−n−プロピル]−β−フエネチル
アミン(化合物()〕・塩酸塩
()塩酸塩を製造する公知の技術としては、い
くつかあるが、特公昭58−25656号及び特公昭62
−21343号に開示されており、そのいくつかを示
せば、4−(4−メトキシフエニル)−3−ブテン
−2−オンを水素化し、得られた還元混合物にホ
モベラトリルアミンを添加し、次いで水素化を行
い3,4−ジメトキシ−N−[3−(4−メトキシ
フエニル)−1−メチル−n−プロピル]−β−フ
エネチルアミン(化合物())を得、次いで臭
化水素酸により脱メチル化を行い、ドブタミン
(化合物())塩酸塩を製造する方法である。又
他の方法としては、アニソールと塩化クロトニル
とを反応させ、p−メトキシフエニルプロペニル
ケトンを得、これとホモベラトリルアミンとを反
応させ、3−(3,4−ジメトキシフエニルエチ
ルアミノ)−1−(4−メトキシフエニル)ブタン
−1−オン(化合物())を得、次いで水素化
し、化合物()を得る。更にこれを臭化水素酸
により脱メチル化反応を行い、ドブタミン塩酸塩
を製造する方法である。これらの方法はいずれ
も、化合物()を得てからこれを臭化水素酸に
よつて脱メチル化を行い化合物()ドブタミン
の塩酸塩を得る方法である。[Prior Art] Conventionally, dobutamine hydrochloride, that is, 3,4-dihydroxy-N-[3-(4-hydroxyphenyl)
-1-methyl-n-propyl]-β-phenethylamine (compound ()) hydrochloride () There are several known techniques for producing hydrochloride, including Japanese Patent Publication No. 58-25656 and Japanese Patent Publication No. 62
21343, to name a few, hydrogenation of 4-(4-methoxyphenyl)-3-buten-2-one and addition of homoveratrylamine to the resulting reduced mixture. , followed by hydrogenation to obtain 3,4-dimethoxy-N-[3-(4-methoxyphenyl)-1-methyl-n-propyl]-β-phenethylamine (compound ()), followed by hydrobromic acid This is a method for producing dobutamine (compound ()) hydrochloride by performing demethylation. Another method is to react anisole with crotonyl chloride to obtain p-methoxyphenylpropenyl ketone, and react this with homoveratrylamine to obtain 3-(3,4-dimethoxyphenylethylamino). -1-(4-methoxyphenyl)butan-1-one (compound ()) is obtained, and then hydrogenated to obtain compound (). This is then subjected to a demethylation reaction using hydrobromic acid to produce dobutamine hydrochloride. In all of these methods, the compound () is obtained and then demethylated with hydrobromic acid to obtain the hydrochloride of the compound () dobutamine.
このような従来の製法において、化合物()
を臭化水素酸により脱メチル化し化合物()を
製する際、有機溶媒を多量に用いておりそのため
反応終了後、多量の有機溶媒及び臭化水素酸を留
去せねばならず、反応物が着色し、目的物の精製
が容易であるとは言えず、よりよい方法が望まれ
ていた。
In such conventional manufacturing methods, the compound ()
When producing compound () by demethylating with hydrobromic acid, a large amount of organic solvent is used, and therefore, after the reaction is completed, a large amount of organic solvent and hydrobromic acid must be distilled off, and the reactant is It is colored, and it cannot be said that purification of the target product is easy, and a better method has been desired.
以上のような従来法における問題点を解決すべ
く鋭意研究を行つた結果、次亜リン酸塩の存在
下、3−(3,4−ジメトキシフエニルエチルア
ミノ)−1−(4−メトキシフエニル)ブタン−1
−オン(化合物())またはその酸付加塩と臭
化水素酸とを反応させることにより、新規の物質
である3−(3,4−ジヒドロキシフエニルエチ
ルアミノ)−1−(4−ヒドロキシフエニル)ブタ
ン−1−オン(化合物())又はその酸付加塩
を合成し、次いでその酸付加塩をパラジウム触媒
の存在下で水素化分解することにより副生物が少
なく、着色の程度の少ない3,4−ジヒドロキシ
−N−[3−(4−ヒロドキシフエニル)−1−メ
チル−n−プロピル]−β−フエネチルアミン
(ドブタミン、化合物())・塩酸塩を製造する
方法を見出し本発明を完成した。
As a result of intensive research to solve the problems in the conventional methods as described above, we found that 3-(3,4-dimethoxyphenylethylamino)-1-(4-methoxyphenyl) was produced in the presence of hypophosphite. enyl)butane-1
-one (compound ()) or its acid addition salt and hydrobromic acid, a new substance 3-(3,4-dihydroxyphenylethylamino)-1-(4-hydroxyphenyl) Enyl)butan-1-one (compound ()) or its acid addition salt is synthesized, and then the acid addition salt is hydrogenolyzed in the presence of a palladium catalyst to produce less by-products and less coloring. , 4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methyl-n-propyl]-β-phenethylamine (dobutamine, compound ()) hydrochloride was discovered and the present invention was achieved. completed.
本発明の概略の合成ルートを化学式で示せば次
の通りである。 The general synthetic route of the present invention is shown by a chemical formula as follows.
本発明を更に詳細に説明すると、本発明の特徴
は、次亜リン酸塩の存在下、化合物()又はそ
の酸付加温を臭化水素酸により脱メチル化して新
規の化合物()又はその酸付加塩を得るに際し
て、有機溶媒を使用することなく、臭化水素酸の
みで反応を完結させることができ、又副生物の生
成が少なく、主生成物の着色の程度もより低くす
ることができる。次いで化合物()酸付加塩を
還元して目的物のドブタミン(化合物())・塩
酸塩を得るが、その結晶化による精製も比較的容
易である。 To explain the present invention in more detail, the feature of the present invention is to demethylate the compound () or its acid addition temperature with hydrobromic acid in the presence of hypophosphite to form a novel compound () or its acid addition temperature. When obtaining an addition salt, the reaction can be completed with only hydrobromic acid without using an organic solvent, and less by-products are produced, and the degree of coloration of the main product can be lowered. . The acid addition salt of Compound () is then reduced to obtain the target dobutamine (Compound ()) hydrochloride, which is also relatively easy to purify by crystallization.
次に本発明の各工程を更に詳細に説明する。 Next, each step of the present invention will be explained in more detail.
先ず第一の工程では、化合物()から臭化水
素酸により化合物()を得るが、臭化水素数を
過剰に用いるため、化合物()の臭化水素酸塩
が通常得られる。この塩を次工程で還元する場合
は、通常、この塩を臭化水素酸以外の酸、例えば
塩酸、硫酸、酢酸、メタンスルホン酸、エタンス
ルホン酸等の酸の塩に変換後、還元する。化合物
()の臭化水素酸塩を他の酸付加塩に変換する
方法としては、2通りあり、一つは、化合物
()の臭化水素酸塩に臭化水素以外の塩酸、硫
酸等の酸を加え、臭化水素酸を除去し置換する方
法であり、他一つは、化合物()の臭化水素酸
塩にアルカリを加え中和して遊離塩基の化合物
()を得、これに臭化水素酸以外の酸を加え、
化合物()の塩を形成せしめる方法である。
又、本第一工程は、次亜リン酸塩、例えば次亜リ
ン酸ナトリウム、次亜リン酸カリウム等の存在下
で行えば、副生物の生成や反応液の着色の程度を
一層低く抑えることができ、この次亜リン酸塩の
使用量は通常、化合物()又はその酸付加塩1
重量部に対して、0.01〜1.0重量部使用でき、好
ましくは0.1〜0.5重量部である。本工程において
使用する臭化水素酸は、47wt%前後の濃度のも
のが一般的に用いられ、その使用量は、化合物
()又はその酸付加塩1重量部に対して10〜40
重量部の範囲で使用され、20〜30重量部が好まし
く用いられる。反応温度は60℃〜環流温度(約
126℃)であり、温度が低いと反応の進行が遅く、
大体90℃以上が好ましい。反応時間は臭化水素酸
の使用量、反応温度によつて異なるが、大体2〜
8時間である。化合物()又はその酸付加塩を
臭化水素酸により脱メチル化反応後、冷却すると
化合物()が通常、臭化水素酸塩として析出す
る。これを、ろ取、水洗、乾燥して化合物()
の臭化水素酸塩を得る。得られた臭化水素酸塩
を、水に溶かしアルカリにより中和することによ
り遊離塩基の化合物()が得られる。この遊離
塩基()又はその臭化水素酸塩を、臭化水素酸
以外の酸、例えば、塩酸、硫酸等の酸の水溶液と
煮沸すれば、化合物()の酸付加塩が得られ、
またさらにメタノール等で再結晶すれば高純度の
化合物()の酸付加塩が得られる。 First, in the first step, compound () is obtained from compound () by using hydrobromic acid, but since an excessive amount of hydrogen bromide is used, the hydrobromide salt of compound () is usually obtained. When this salt is reduced in the next step, the salt is usually converted to a salt of an acid other than hydrobromic acid, such as hydrochloric acid, sulfuric acid, acetic acid, methanesulfonic acid, ethanesulfonic acid, and the like, and then reduced. There are two methods for converting the hydrobromide of compound () to other acid addition salts. One is to convert the hydrobromide of compound () into an acid addition salt other than hydrogen bromide, such as hydrochloric acid or sulfuric acid. The other method is to add an acid and remove and replace the hydrobromic acid.The other method is to neutralize the hydrobromide of the compound () by adding an alkali to obtain the free base of the compound (). Add an acid other than hydrobromic acid,
This is a method of forming a salt of compound ().
Furthermore, if this first step is carried out in the presence of a hypophosphite, such as sodium hypophosphite or potassium hypophosphite, the generation of by-products and the degree of coloration of the reaction solution can be further suppressed. The amount of hypophosphite used is usually 1% of the compound () or its acid addition salt.
It can be used in an amount of 0.01 to 1.0 parts by weight, preferably 0.1 to 0.5 parts by weight. Hydrobromic acid used in this step generally has a concentration of around 47% by weight, and the amount used is 10 to 40% by weight per 1 part by weight of the compound () or its acid addition salt.
It is used in a range of parts by weight, preferably 20 to 30 parts by weight. The reaction temperature ranges from 60℃ to reflux temperature (approximately
126℃), and the lower the temperature, the slower the reaction progresses.
Generally, the temperature is preferably 90°C or higher. The reaction time varies depending on the amount of hydrobromic acid used and the reaction temperature, but is approximately 2 to 30 minutes.
It is 8 hours. When compound () or its acid addition salt is demethylated with hydrobromic acid and then cooled, compound () usually precipitates as a hydrobromide salt. This is collected by filtration, washed with water, and dried to form a compound ()
The hydrobromide salt is obtained. The resulting hydrobromide salt is dissolved in water and neutralized with an alkali to obtain the free base compound (). If this free base () or its hydrobromide salt is boiled with an aqueous solution of an acid other than hydrobromic acid, such as hydrochloric acid or sulfuric acid, an acid addition salt of the compound () is obtained,
Further, by further recrystallizing with methanol or the like, a highly pure acid addition salt of the compound () can be obtained.
次に、第二の工程、即ち化合物()又はその
酸付加塩から化合物()ドブタミンの塩酸を合
成する工程においては、カルボニルをメチレンに
還元(水素分解)する際に行なわれる一般的な還
元法がとられる。例えば、パラジウム−カーボ
ン、白金黒、酸化白金等の触媒を使用する水素化
分解により、化合物()の、臭化水素酸以外の
酸の付加塩等から容易に化合物()ドブタミン
の塩酸塩を合成することができる。本工程におい
て、触媒としてパラジウム−カーボン等を用いた
水素化分解を行つた場合、極性溶媒および酸の存
在下で、常圧ないしは加圧水素下で反応を行うこ
とにより目的化合物()の酸付加塩が得られ
る。この場合の極性溶媒としては、水、メタノー
ル、エタノール、等が挙げられ、その使用量は化
合物()又はその酸付加塩に対して重量で大体
5〜50倍量で、好ましくは大体10〜30倍量であ
る。また酸としては、塩酸、硫酸、酢酸、メタン
スルホン酸、エタンスルホン酸等の酸並びにこれ
らの混合酸等が挙げられ、その使用量は化合物
()又はその酸付加塩に対して重量で大体0.01
〜3.0倍量で、好ましくは0.1〜1.0倍量である。ま
たパラジウム(5%)−カーボンを触媒として用
いた場合、その使用量は重量で化合物()又は
その酸付加塩に対して大体0.05〜0.5倍量位であ
り、好ましくは0.1〜0.3倍量である。この際の水
素圧は大体2〜10Kg/cm2である。反応温度は大体
10〜80℃位で、好ましくは20〜70℃位である。還
元反応は化合物()又はその酸付加塩に対して
化学量論量の水素が反応したときに終了とする。
その後、触媒をろ過し、濃縮後、淡黄色結晶性残
留物として化合物()の酸付加塩を得る。次い
で、その酸付加塩が塩酸塩以外の酸付加塩である
場合は、塩酸塩に変換する。要すれば、その後、
塩酸水溶液で再結晶すると白色結晶の化合物
()(ドブタミン)の塩酸塩が得られる。 Next, in the second step, that is, the step of synthesizing hydrochloric acid of compound () dobutamine from compound () or its acid addition salt, a general reduction method is used when carbonyl is reduced to methylene (hydrolysis). is taken. For example, the hydrochloride of the compound () dobutamine can be easily synthesized from the addition salt of an acid other than hydrobromic acid of the compound () by hydrogenolysis using a catalyst such as palladium-carbon, platinum black, or platinum oxide. can do. In this step, when hydrogenolysis is performed using palladium-carbon or the like as a catalyst, the acid addition salt of the target compound () is obtained by carrying out the reaction under normal pressure or pressurized hydrogen in the presence of a polar solvent and an acid. is obtained. Examples of the polar solvent in this case include water, methanol, ethanol, etc., and the amount used is approximately 5 to 50 times the weight of the compound () or its acid addition salt, preferably approximately 10 to 30 times the weight of the compound () or its acid addition salt. It's double the amount. Examples of acids include acids such as hydrochloric acid, sulfuric acid, acetic acid, methanesulfonic acid, and ethanesulfonic acid, as well as mixed acids thereof, and the amount used is approximately 0.01% by weight based on the compound () or its acid addition salt.
~3.0 times the amount, preferably 0.1 to 1.0 times the amount. When palladium (5%)-carbon is used as a catalyst, the amount used is approximately 0.05 to 0.5 times, preferably 0.1 to 0.3 times, the weight of the compound () or its acid addition salt. be. The hydrogen pressure at this time is approximately 2 to 10 kg/cm 2 . The reaction temperature is approximately
The temperature is about 10 to 80°C, preferably about 20 to 70°C. The reduction reaction is terminated when a stoichiometric amount of hydrogen reacts with the compound () or its acid addition salt.
Thereafter, the catalyst is filtered and after concentration the acid addition salt of compound () is obtained as a pale yellow crystalline residue. Next, when the acid addition salt is an acid addition salt other than hydrochloride, it is converted to the hydrochloride. If necessary, then
Recrystallization from an aqueous hydrochloric acid solution yields the hydrochloride of compound () (dobutamine) as white crystals.
以下に本発明を実施例で示すが、製法について
はこれらに限定されるものではない。
The present invention will be illustrated below with examples, but the manufacturing method is not limited thereto.
実施例 1
3−(3,4−ジヒドロキシフエニルエチルア
ミノ)−1−(4−ヒドロキシフエニル)ブタン
−1−オンの製造。Example 1 Preparation of 3-(3,4-dihydroxyphenylethylamino)-1-(4-hydroxyphenyl)butan-1-one.
300ml四径フラスコに3−(3,4−ジメトキシ
フエニルエチルアミノ)−1−(4−メトキシフエ
ニル)ブタン−1−オン塩酸塩10g、47wt%臭
化水素酸262g及び次亜リン酸ナトリウム−水和
物2.5gを添加し、環流下で2時間反応した。次
いでこの反応混合物を冷却し、析出した結晶をろ
過、乾燥して淡桃色結晶7.5gを得た。次いでこ
の粗生成物を150mlの温水に溶解し、活性炭で脱
色後、ろ液に1N水酸化ナトリウム水溶液をPHが
7.0になるまで加え、析出した白色結晶をろ過、
乾燥して3−(3,4−ジヒドロキシフエニルエ
チルアミノ)−1−(4−ヒドロキシフエニル)ブ
タン−1−オン5.0gを得た。 In a 300ml four-bore flask, add 10g of 3-(3,4-dimethoxyphenylethylamino)-1-(4-methoxyphenyl)butan-1-one hydrochloride, 262g of 47wt% hydrobromic acid, and sodium hypophosphite. - 2.5 g of hydrate was added and reacted under reflux for 2 hours. The reaction mixture was then cooled, and the precipitated crystals were filtered and dried to obtain 7.5 g of pale pink crystals. Next, this crude product was dissolved in 150 ml of warm water, and after decolorizing with activated carbon, the filtrate was diluted with 1N aqueous sodium hydroxide solution until the pH was adjusted.
7.0, filter the precipitated white crystals,
After drying, 5.0 g of 3-(3,4-dihydroxyphenylethylamino)-1-(4-hydroxyphenyl)butan-1-one was obtained.
融点:138〜141℃
赤外線吸収スペクトル(νmax cm-1、KBr錠)
3450;3120;1650;1590
1510;1420;1380;1290
1240;1180;850
元素分析値(C18H21NO4として)
理論値(%) 実測値(%)
C 68.55 68.24
H 6.71 6.57
N 4.44 4.58
実施例 2
3−(3,4−ジヒドロキシフエニルエチルア
ミノ)−1−(4−ヒドロキシフエニル)ブタン
−1−オン酸付加塩の製造。Melting point: 138-141℃ Infrared absorption spectrum (νmax cm -1 , KBr tablet) 3450; 3120; 1650; 1590 1510; 1420; 1380; 1290 1240; 1180; 850 Elemental analysis value (as C 18 H 21 NO 4 ) Theory Value (%) Actual value (%) C 68.55 68.24 H 6.71 6.57 N 4.44 4.58 Example 2 3-(3,4-dihydroxyphenylethylamino)-1-(4-hydroxyphenyl)butan-1-oic acid Production of addition salts.
300ml四径フラスコに3−(3,4−ジメトキシ
フエニルエチルアミノ)−1−(4−メトキシフエ
ニル)ブタン−1−オン塩酸塩10g、47wt%臭
化水素酸218gおよび次亜リン酸ナトリウム−水
和物2.5gを添加し、環流下で3時間反応した。
次いでこの反応混合物を冷却し、析出した結晶を
ろ過、乾燥して、淡桃色結晶8.0gを得た。次い
でこの粗生成物を80mlの温水に溶解し、活性炭で
脱色後、冷却、晶出、ろ過、乾燥して白色結晶状
の3−(3,4−ジヒドロキシフエニルエチルア
ミノ)−1−(4−ヒドロキシフエニル)ブタン−
1−オン臭化水素酸塩6.4gを得た。 In a 300ml four-bore flask, add 10g of 3-(3,4-dimethoxyphenylethylamino)-1-(4-methoxyphenyl)butan-1-one hydrochloride, 218g of 47wt% hydrobromic acid, and sodium hypophosphite. - 2.5 g of hydrate was added and reacted under reflux for 3 hours.
The reaction mixture was then cooled, and the precipitated crystals were filtered and dried to obtain 8.0 g of pale pink crystals. Next, this crude product was dissolved in 80 ml of warm water, decolorized with activated carbon, cooled, crystallized, filtered, and dried to obtain white crystalline 3-(3,4-dihydroxyphenylethylamino)-1-(4 -Hydroxyphenyl)butane-
6.4 g of 1-one hydrobromide was obtained.
融点188〜190℃
赤外線吸収スペクトル(νmax cm-1、KBr錠):
3400;3320;3260;3000
2800;1660;1600;1520
1280;1210;1170
元素分析値(C18H22BrNO4として)
理論値(%) 実測値(%)
C 54.56 54.47
H 5.60 5.75
N 3.53 3.53
Br 20.41 20.25
次いでこの臭化水素酸塩を4N塩酸で再結晶す
ると白色結晶状の3−(3,4−ジヒドロキシフ
エニルエチルアミノ)−1−(4−ヒドロキシフエ
ニル)ブタン−1−オン塩酸塩が得られた。Melting point 188-190℃ Infrared absorption spectrum (νmax cm -1 , KBr tablet): 3400; 3320; 3260; 3000 2800; 1660; 1600; 1520 1280; 1210; 1170 Elemental analysis value (as C 18 H 22 BrNO 4 ) Theory Value (%) Actual value (%) C 54.56 54.47 H 5.60 5.75 N 3.53 3.53 Br 20.41 20.25 Next, this hydrobromide salt was recrystallized from 4N hydrochloric acid to give white crystalline 3-(3,4-dihydroxyphenylethyl Amino)-1-(4-hydroxyphenyl)butan-1-one hydrochloride was obtained.
融点:179〜181℃
赤外線吸収スペクトル(νmax cm-1、KBr錠):
3375;3275;3200;2800;
1658;1600;1518;1282;
1210;1170
元素分析値(C18H22ClNO4として)
理論値(%) 実測値(%)
C 61.45 61.23
H 6.30 6.25
N 3.98 4.09
Cl 10.08 10.26
実施例 3
3,4−ジヒドロキシ−N−[3−(4−ヒロド
キシフエニル)−1−メチル−n−プロピル]−
β−フエネチルアミン塩酸塩の製造。Melting point: 179-181℃ Infrared absorption spectrum (νmax cm -1 , KBr tablet): 3375; 3275; 3200; 2800; 1658; 1600; 1518; 1282; 1210; 1170 Elemental analysis value (as C 18 H 22 ClNO 4 ) Theoretical value (%) Actual value (%) C 61.45 61.23 H 6.30 6.25 N 3.98 4.09 Cl 10.08 10.26 Example 3 3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methyl-n -propyl]-
Production of β-phenethylamine hydrochloride.
ガラス製オートクレーブに3−(3,4−ジヒ
ドロキシフエニルエチルアミノ)−1−(4−ヒド
ロキシフエニル)ブタン−1−オン塩酸塩10g、
メタノール150ml、メタンスルホン酸2.7gおよび
5%パラジウム−カーボン2.5gを添加し、4
Kg/cm2の水素圧下、約60℃の温度で水素化分解し
た。8時間後に化学量論量の水素の吸収が認めら
れた。その後、触媒をろ別し、ろ液から溶媒を留
去して淡黄色結晶性残留物12.5gを得た。この残
留物を100mlの温水に溶解し、活性炭で脱色し、
そのろ液に水100ml、濃塩酸100mlを加え、還流下
で1時間撹拌した。その後冷却し、析出した白色
沈澱をろ過した。これを再度4N塩酸で再結晶し
て目的物の3,4−ジヒドロキシ−N−[3−(4
−ヒロドキシフエニル)−1−メチル−n−プロ
ピル]−β−フエネチルアミン塩酸塩4.8gを得
た。融点184〜187℃。 10 g of 3-(3,4-dihydroxyphenylethylamino)-1-(4-hydroxyphenyl)butan-1-one hydrochloride in a glass autoclave;
Add 150 ml of methanol, 2.7 g of methanesulfonic acid and 2.5 g of 5% palladium-carbon,
Hydrogenolysis was carried out at a temperature of about 60° C. under a hydrogen pressure of Kg/cm 2 . A stoichiometric amount of hydrogen was observed to be absorbed after 8 hours. Thereafter, the catalyst was filtered off, and the solvent was distilled off from the filtrate to obtain 12.5 g of a pale yellow crystalline residue. This residue was dissolved in 100 ml of warm water, decolorized with activated carbon,
100 ml of water and 100 ml of concentrated hydrochloric acid were added to the filtrate, and the mixture was stirred under reflux for 1 hour. Thereafter, the mixture was cooled and the precipitated white precipitate was filtered. This was recrystallized again from 4N hydrochloric acid to obtain the target product, 3,4-dihydroxy-N-[3-(4
4.8 g of -hydroxyphenyl)-1-methyl-n-propyl]-β-phenethylamine hydrochloride was obtained. Melting point 184-187℃.
実施例 4
3,4−ジヒドロキシ−N−[3−(4−ヒドロ
キシフエニル)−1−メチル−n−プロピル]−
β−フエネチルアミン塩酸塩の製造。Example 4 3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methyl-n-propyl]-
Production of β-phenethylamine hydrochloride.
ガラス製オートクレーブに3−(3,4−ジヒ
ドロキシフエニルエチルアミノ)−1−(4−ヒド
ロキシフエニル)ブタン−1−オン塩酸塩10g、
メタノール150ml、濃塩酸5mlおよび5%パラジ
ウム−カーボン2.5gを添加し、4Kg/cm2の水素
圧下、約60℃の温度で水素化分解した。7時間後
に化学量論量の水素の吸収が認められた。その
後、触媒をろ別し、ろ液から溶媒を留去して淡黄
色残留物14.5gを得た。この残留物を100mlの温
水に溶解し、活性炭で脱色した。この溶液に濃塩
酸3mlを添加し、析出した黄色油状物をデカント
して除き、更に水100ml、濃塩酸100mlを加え、還
流下で1時間撹拌した。その後、冷却し、析出し
た白色沈澱をろ過した。これを再度4N塩酸で再
結晶して目的物の3,4−ジヒドロキシ−N−
[3−(4−ヒドロキシフエニル)−1−メチル−
n−プロピル]−β−フエネチルアミン塩酸塩3.8
gを得た。融点184〜187℃。 10 g of 3-(3,4-dihydroxyphenylethylamino)-1-(4-hydroxyphenyl)butan-1-one hydrochloride in a glass autoclave;
150 ml of methanol, 5 ml of concentrated hydrochloric acid and 2.5 g of 5% palladium-carbon were added and hydrogenolyzed at a temperature of about 60° C. under a hydrogen pressure of 4 kg/cm 2 . A stoichiometric amount of hydrogen was observed to be absorbed after 7 hours. Thereafter, the catalyst was filtered off, and the solvent was distilled off from the filtrate to obtain 14.5 g of a pale yellow residue. This residue was dissolved in 100 ml of warm water and decolorized with activated carbon. 3 ml of concentrated hydrochloric acid was added to this solution, the precipitated yellow oil was removed by decantation, 100 ml of water and 100 ml of concentrated hydrochloric acid were added, and the mixture was stirred under reflux for 1 hour. Thereafter, the mixture was cooled and the precipitated white precipitate was filtered. This was recrystallized again from 4N hydrochloric acid to obtain the desired product, 3,4-dihydroxy-N-
[3-(4-hydroxyphenyl)-1-methyl-
n-propyl]-β-phenethylamine hydrochloride 3.8
I got g. Melting point 184-187℃.
本発明方法によれば、第一工程において、有機
溶媒を使用せず次亜リン酸塩を添加して実施する
ため、得られた中間体の、着色の程度及び副生物
の生成をより低く抑えることができ、結果として
第二工程において、最終的に得られるドブタミ
ン・塩酸塩の着色の程度も少なく、且つその精製
も比較的容易である。
According to the method of the present invention, since the first step is carried out by adding hypophosphite without using an organic solvent, the degree of coloring of the obtained intermediate and the generation of by-products are kept to a lower level. As a result, in the second step, the degree of coloring of the finally obtained dobutamine hydrochloride is small, and its purification is relatively easy.
Claims (1)
エチルアミノ)−1−(4−ヒドロキシフエニル)
ブタン−1−オン及びその酸付加塩。 2 次亜リン酸塩の存在下において、3−(3,
4−ジメトキシフエニルエチルアミノ)−1−(4
−メトキシフエニル)ブタン−1−オン又はその
酸付加塩を臭化水素酸と反応させることからな
る、3−(3,4−ジヒドロキシフエニルエチル
アミノ)−1−(4−ヒドロキシフエニル)ブタン
−1−オン又はその酸付加塩を製造する方法。 3 3−(3,4−ジヒドロキシフエニルエチル
アミノ)−1−(4−ヒドロキシフエニル)ブタン
−1−オン酸付加塩を、パラジウム触媒の存在下
で水素化分解することからなる、3,4−ジヒド
ロキシ−N−[3−(4−ヒドロキシフエニル)−
1−ミチル−n−プロピル]−β−フエネチルア
ミン・塩酸塩を製造する方法。[Claims] 1 formula 3-(3,4-dihydroxyphenylethylamino)-1-(4-hydroxyphenyl) represented by
Butan-1-one and its acid addition salts. 2 In the presence of hypophosphite, 3-(3,
4-dimethoxyphenylethylamino)-1-(4
3-(3,4-dihydroxyphenylethylamino)-1-(4-hydroxyphenyl) by reacting -methoxyphenyl)butan-1-one or its acid addition salt with hydrobromic acid. A method for producing butan-1-one or an acid addition salt thereof. 3, consisting of hydrogenolysis of 3-(3,4-dihydroxyphenylethylamino)-1-(4-hydroxyphenyl)butan-1-one acid addition salt in the presence of a palladium catalyst. 4-dihydroxy-N-[3-(4-hydroxyphenyl)-
A method for producing 1-methyl-n-propyl]-β-phenethylamine hydrochloride.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63162883A JPH0211544A (en) | 1988-06-30 | 1988-06-30 | Dopamine derivative and preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63162883A JPH0211544A (en) | 1988-06-30 | 1988-06-30 | Dopamine derivative and preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0211544A JPH0211544A (en) | 1990-01-16 |
JPH0424343B2 true JPH0424343B2 (en) | 1992-04-24 |
Family
ID=15763074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63162883A Granted JPH0211544A (en) | 1988-06-30 | 1988-06-30 | Dopamine derivative and preparation thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0211544A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4135755B2 (en) | 2006-07-19 | 2008-08-20 | 株式会社日立製作所 | Information recording / reproducing apparatus and data moving method |
-
1988
- 1988-06-30 JP JP63162883A patent/JPH0211544A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH0211544A (en) | 1990-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL163884B1 (en) | Method of obtaining fluoxetine and its additive acid salt | |
DE2603600A1 (en) | ALPHA-AMINOMETHYL-5-HYDROXY-2-PYRIDINEMETHANOL DERIVATIVES | |
EP0418925B1 (en) | Method of producing (S)-4-hydroxymethyl-gamma-lactone | |
SU843749A3 (en) | Method of preparing 4a,9b-trans-hexahydro-gamma-carboline | |
US4610828A (en) | Process for preparing L-carnitine and salts thereof | |
NO773300L (en) | PROCEDURE FOR THE PREPARATION OF NEW acetic acid derivatives | |
JPH0424343B2 (en) | ||
US4073798A (en) | Preparation of ethylamine derivatives | |
DE1543777B2 (en) | Process for the preparation of alpha low alkyl beta (4 hydroxy phenyl) alanines | |
US3803177A (en) | Process for production of eriodictyol | |
CN111848496B (en) | Preparation method of tofacitinib intermediate amine and double hydrochloride thereof | |
JP4260941B2 (en) | Azetidine-3-ol | |
KR950005737B1 (en) | Separating method of component from gingkolide complex | |
JP2002308851A (en) | PRODUCTION METHOD FOR 6-AMINOMETHYL-6,11-DIHYDRO-5H- DIBENZ[b,e]AZEPINE | |
DE3020604A1 (en) | METHOD FOR PRODUCING BROMHEXINE | |
GB2181432A (en) | Chemical process | |
Jacobs et al. | THE ERGOT ALKALOIDS: XVIII. THE PRODUCTION OF A BASE FROM LYSERGIC ACID AND ITS COMPARISON WITH SYNTHETIC 6, 8-DIMETHYLERGOLINE | |
DE1620206C (en) | N-Cyclopropylmethyl-6,14-endo-ethanotetrahydronororipavine and their salts, processes for their preparation and pharmaceutical preparations containing these compounds | |
US5169955A (en) | Process for producing 2-hydroxyquinoxaline derivatives | |
JP2639709B2 (en) | Novel method for producing 4'-demethyl epipodophyllotoxin derivative | |
JPH0692916A (en) | Production of 3'-amino-2'-hydroxyacetophenone | |
KR100342919B1 (en) | A preparation and purification for trans isomer of tramadol hydrochloride | |
JPH0143731B2 (en) | ||
Snyder et al. | The Preparation of Unsymmetrical Diaryl Amines. 5-Phenylamino-6-methoxy-8-(3-diethylaminopropylamino)-quinoline1 | |
SU595312A1 (en) | Method of preparing pyrimidine 2,4,6-substituted perchlorates |